Related Experiment Videos
Stone screening and follow-up are necessary?
British Journal of Urology
|January 1, 1975
Summary
A significant 60% of renal stone patients have treatable metabolic issues like idiopathic hypercalciuria. Untreated, these conditions lead to high stone recurrence, necessitating follow-up and controlled clinical trials for effective medical treatment.
Area of Science:
- Nephrology
- Urology
- Metabolic Medicine
Background:
- Renal stones (kidney stones) affect a significant patient population.
- Identifying underlying metabolic abnormalities is crucial for effective management.
- High recurrence rates underscore the need for improved treatment strategies.
Purpose of the Study:
- To determine the prevalence of treatable metabolic abnormalities in patients with renal stones.
- To identify the most common metabolic causes of kidney stone formation.
- To assess the impact of untreated metabolic abnormalities on stone recurrence and renal changes.
Main Methods:
- Retrospective analysis of 120 patients diagnosed with renal stones.
- Biochemical screening for metabolic abnormalities.
- Evaluation of stone recurrence rates and renal changes in relation to metabolic status.
Main Results:
- 60% of patients presented with a treatable metabolic abnormality.
- Idiopathic hypercalciuria and incomplete renal tubular acidosis were the most frequent diagnoses.
- Untreated idiopathic hypercalciuria and renal tubular acidosis were linked to high stone recurrence and renal damage.
Conclusions:
- A high proportion of renal stone patients harbor identifiable and treatable metabolic disorders.
- Systematic follow-up and investigation for metabolic causes are essential in renal stone management.
- Medical interventions for these conditions should be validated through controlled clinical trials.